PAD4 has been shown to be activated in response to hypoxia in cancer [66], linked to hypoxia in autoimmune disease [100], and upregulated in malignant glioma cells in hypoxia challenge [58] as well as in neurodegeneration [55]. Here, PADI4 is linked to cancer.